Ketamine/Placebo Family History Positive Study
Conditions
Alcoholism
What is the purpose of this trial?
The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high-risk individuals that may lead to the transition from moderate to excessive use of alcohol.
Participation Guidelines
- Age:
- 21 Years - 30 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- VA Connecticut Healthcare System
Yale University - Dates:
- March 2001
- Last Updated:
- February 14, 2013
- Study HIC#:
- 0103012310
Clinicaltrials.gov ID: NCT00588952


